Impact of the use of autologous stem cell transplantation at first relapse both in naive and previously rituximab exposed follicular lymphoma patients treated in the GELA/GOELAMS FL2000 study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.